학술논문

Comorbid hepatitis C does not modulate prevalence or severity of diabetic retinopathy
Document Type
Clinical report
Source
Clinical Ophthalmology. September, 2019, p1681, 7 p.
Subject
Diabetic retinopathy -- Care and treatment -- Comparative analysis
Prevalence studies (Epidemiology) -- Comparative analysis
Biological response modifiers -- Comparative analysis
Type 2 diabetes -- Care and treatment -- Comparative analysis
Medical research -- Comparative analysis
Infection -- Care and treatment -- Comparative analysis
Hepatitis C virus -- Comparative analysis
Liver cirrhosis -- Care and treatment -- Comparative analysis
Interferon -- Comparative analysis
Comorbidity -- Care and treatment -- Comparative analysis
Glycosylated hemoglobin -- Comparative analysis
Diabetics -- Care and treatment -- Comparative analysis
HIV
Hemoglobins
Language
English
ISSN
1177-5483
Abstract
Purpose: There are limited and conflicting data regarding the impact of comorbid hepatitis C virus (HCV) infection on diabetic retinopathy (DR). This study sought to compare the prevalence and severity of DR among patients with diabetes mellitus (DM) with and without HCV. Patients and methods: This was a retrospective, case--control study of patients with DM comparing 120 patients with comorbid HCV and 120 age-matched controls. DR prevalence and several measures of severity were compared between groups. Subgroup analyses were performed among HCV patients with cirrhosis, comorbid HIV, or history of treatment with interferon. Statistical analysis for between-group comparisons utilized both univariate and multivariate analyses. Results: Cases and controls exhibited similar baseline characteristics: average hemoglobin A1c, DM duration, and age (p>0.05). Among cases and controls, there was no difference in DR prevalence (35.8% versus 42.5%, respectively, p=0.29) or severity (p>0.05). Within the HCV subgroup, DR severity was reduced in patients with HIV or cirrhosis. However, multivariate analysis identified reduced DM duration in these subgroups as the primary contributor to lesser DR severity, rather than HIV or cirrhosis. Conclusion: In this study, comorbid HCV did not modulate the prevalence or severity of DR among patients with DM. These findings may inform clinical monitoring among HCV-positive diabetics undergoing ophthalmic evaluation. Keywords: cirrhosis, diabetes mellitus, retinopathy, hepatitis
Introduction Diabetes mellitus (DM) is among the most significant drivers of morbidity in the United States, diagnosed in 23 million patients and precipitating more than $245 billion of direct and [...]